{"filing":{"accession_number":"0001628280-26-054309","cik":"0001818093","ticker":"SKIN","company_name":"SkinHealth Systems Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"skin-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828026054309/skin-20260806.htm"},"events":[{"id":25898,"run_id":23513,"accession_number":"0001628280-26-054309","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"SkinHealth Systems disclosed its Q2 2026 financial results via press release (Exhibit 99.1) on August 6, 2026, reporting net sales of $72.1 million (down 7.8% YoY), a net loss of $(2.7) million (vs. net income of $19.7 million in Q2 2025), and adjusted EBITDA of $17.0 million. The filing includes comprehensive financial statements, regional metrics, and revised 2026 guidance. This is a standard quarterly earnings release under Item 2.02.","company_name":"SkinHealth Systems Inc.","ticker":"SKIN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26833,"accession_number":"0001628280-26-054309","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"SkinHealth Systems disclosed its Q2 2026 financial results via press release (Exhibit 99.1) on August 6, 2026, reporting net sales of $72.1 million (down 7.8% YoY), a net loss of $(2.7) million (vs. net income of $19.7 million in Q2 2025), and adjusted EBITDA of $17.0 million. The filing includes comprehensive financial statements, regional metrics, and revised 2026 guidance. This is a standard quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:41:54.129729+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26833,"accession_number":"0001628280-26-054309","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"SkinHealth Systems disclosed its Q2 2026 financial results via press release (Exhibit 99.1) on August 6, 2026, reporting net sales of $72.1 million (down 7.8% YoY), a net loss of $(2.7) million (vs. net income of $19.7 million in Q2 2025), and adjusted EBITDA of $17.0 million. The filing includes comprehensive financial statements, regional metrics, and revised 2026 guidance. This is a standard quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:41:54.129729+00:00","company_name":"SkinHealth Systems Inc.","ticker":"SKIN","filing_date":"2026-08-06"}]}